JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, cilt.51, sa.4, ss.454-457, 2010 (SCI-Expanded)
Objective: Octreotide has been suggested as a medical treatment option in refractory cases of primary intestinal lymphangiectasia (IL). There are few data about the long-term effect and safety of octreotide for IL in the literature. In the present article we analyzed pediatric cases of primary IL with long-term octreotide treatment and discussed its safety profile.